Peripheral and Central Nervous System Biomarkers of Inflammation in Functional Seizures: Assessment with Magnetic Resonance Spectroscopy.
Journal Information
Full Title: Neuropsychiatr Dis Treat
Abbreviation: Neuropsychiatr Dis Treat
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure Dr Jerzy P Szaflarski is funded by National Institutes of Health, CDMRP, State of Alabama, Shor Foundation for Epilepsy Research, UCB Pharma Inc., and NeuroPace Inc. He has served on consulting/advisory boards for Greenwich Biosciences Inc., NeuroPace, Inc., Serina Therapeutics Inc., LivaNova Inc., UCB Pharma Inc., iFovea, AdCel Biopharma LLC, and Elite Medical Experts LLC. He serves as an editorial board member for Epilepsy & Behavior, Journal of Epileptology (associate editor), Epilepsy & Behavior Reports (Editor-in-Chief), Journal of Medical Science, Epilepsy Currents (contributing editor), and Folia Medica Copernicana."
"We would like to thank Holly Yazdi for assistance with participant recruitment and data collection. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. This study was supported by the UAB Department of Neurology and the UAB Epilepsy Center. The sponsor was not involved in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. During the data collection and processing stages of the study, Dr Ayushe Sharma was supported by an institutional training grant (T32-NS061788-13) funded by the National Institute of Health and the National Institute of Neurological Disorders and Stroke (NINDS). She is currently supported by a NIH Ruth L. Kirschstein National Research Service Award (1F31NS129288-01) from the NINDS. Disclosure: Dr Jerzy P Szaflarski is funded by National Institutes of Health, CDMRP, State of Alabama, Shor Foundation for Epilepsy Research, UCB Pharma Inc., and NeuroPace Inc. He has served on consulting/advisory boards for Greenwich Biosciences Inc., NeuroPace, Inc., Serina Therapeutics Inc., LivaNova Inc., UCB Pharma Inc., iFovea, AdCel Biopharma LLC, and Elite Medical Experts LLC. He serves as an editorial board member for Epilepsy & Behavior, Journal of Epileptology (associate editor), Epilepsy & Behavior Reports (Editor-in-Chief), Journal of Medical Science, Epilepsy Currents (contributing editor), and Folia Medica Copernicana."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025